Diplomat to Participate in the Raymond James & Associates' 37th Annual Institutional Investors Conference
FLINT, Mich., Feb. 22, 2016 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, Chairman & CEO, and Sean Whelan, CFO, will present at the upcoming Raymond James & Associates' 37th Annual Institutional Investors Conference in Orlando, FL.
Mr. Hagerman and Mr. Whelan are scheduled to present at the conference on Wednesday, March 9, 2016 at 9:15 a.m. Eastern Time. A live audio-only webcast of the presentation and related presentation materials will be available on the investor relations section of the Company's website at ir.diplomat.is. The archived webcast and presentation materials will also be available for 90 days at the same URL.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Bob East, Westwicke Partners
443.213.0500 | email@example.com
Jenny Cretu, Diplomat
810.768.9370 | firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-the-raymond-james--associates-37th-annual-institutional-investors-conference-300223673.html
SOURCE Diplomat Pharmacy, Inc.